반응식
[NH:1]1[CH2:5][CH2:4][N:3]=[C:2]1[C:6]1[CH:12]=[C:11]([O:13][CH3:14])[C:10]([O:15][CH3:16])=[CH:9][C:7]=1[NH2:8].CO[C:19](=O)[CH2:20][C:21](=[O:28])[C:22]1[CH:23]=[N:24][CH:25]=[CH:26][CH:27]=1>>[CH3:16][O:15][C:10]1[C:11]([O:13][CH3:14])=[CH:12][C:6]2[C:2]3[N:3]([CH2:4][CH2:5][N:1]=3)[C:19](/[CH:20]=[C:21](/[C:22]3[CH:23]=[N:24][CH:25]=[CH:26][CH:27]=3)\[OH:28])=[N:8][C:7]=2[CH:9]=1참가 물질
3
실험 절차
A mixture of 2-(4,5-dihydro-1H-imidazol-2-yl)-4,5-dimethoxyaniline (0.15 g, 0.68 mmol) and methyl-3-oxo-3(3-pyridinyl)propanoate (0.20 g, 1.12 mmol) was stirred at 155. for 1 hour. The reaction mixture was purified by column chromatography on silica-gel (dichloromethane/methanol, 25/1) to give (Z)-2-(8,9-dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-1-(3-pyridinyl)ethenol (66.9 mg, 28%) as a yellow solid.
후처리
- customThe reaction mixture was purified by column chromatography on silica-gel (dichloromethane/methanol, 25/1)
출처 및 근거
- ORD 기록
- ord-0944fbcff90e4f7199175239c9b25760
- 출처 데이터셋
- uspto-grants-2009_03
- 특허 번호
- US07511041B2
연결된 노트
불러오는 중…